Two ETFs to Avoid the Health Care Fallout
NEW YORK (TheStreet) -- First Trust NYSE Bio-technology (FBT) and SPDR KBW Regional Banking ETF (KRE) offer two ways to avoid political fallout from the passage of the health care reform bill.
As I have discussed in the past, ETF investors can avoid the political mayhem in the sectors that the bill is directed toward by choosing health care ETFs that focus on bio-tech companies, such as FBT, and financial ETFs that include regional banks such KRE. Year to date, FBT has risen 29.4% while KRE has gone up by 18.7%.
These sub-sectors of health care and financials fall outside the scope of President Obama's reform agenda and will likely see continued upward momentum regardless of the action in Washington.
Late Sunday, the House approved the health care reform bill, clearing the way for an overhaul of the sector after a long, controversial political battle.
If the lobbying efforts of the pharmaceuticals are a good indicator, iShares Dow Jones U.S. Pharmaceuticals (IHE) should benefit. These companies are expected to benefit from the increase demand for pharmaceuticals from the addition of Americans to insurance rolls. Similarly, biotechnology, which wasn't a target of the legislation, is likely to benefit from higher levels of spending. The passage of the bill also affects ETFs that would benefit or suffer from legislation that Obama plans on fighting for later this year. The protests against the proposed health care bill in Washington this weekend show that Republicans have the opportunity to use the bill's passage as a way to foster animosity against the Democrats in this year's mid-term election. If the Republicans can claim more seats in the Senate, they will be in a better position to check the president's plans. In the special election in Massachusetts in January, a mostly Democratic state voted Republican Scott Brown into the Senate, knowing full well that he would jeopardize health care reform. As a result of the Massachusetts election and the passage of the health care overhaul, it looks likely that November's election will not go well for the Democrats, which faces internal strife from those within who are disenchanted with Obama's reform efforts.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV